Boston Scientific Corp. (BSX) announced the erollment of first patient in a clinical trial to evaluate its WallFlex Biliary RX Fully Covered Stent for the treatment of benign bile duct strictures. The multi-center, prospective study plans to enroll 187 patients at 11 centers worldwide over the next 18 months.
The first patient was enrolled by Professor Horst Neuhaus at the Evangelisches Krankenhaus in Dusseldorf, Germany. Lead Investigators in the study are Professor Jacques Deviere of Hospital Erasme in Brussels, and Professor Guido Costamagna of Policlinico Gemelli in Rome.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.